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Abstract
Background: Obesity and depression are both highly prevalent public health disorders and evidence on their
relationship is inconsistent. This study examined whether depressive symptoms are associated with current obesity,
and further, whether obesity in turn is associated with an increased odds of depressive symptoms five years later
after accounting for potential lifestyle confounders and depressive symptoms at baseline.
Methods: Data were obtained from the 1958 British birth cohort (N = 9217 for cross-sectional and 7340 for prospective
analysis). Clinical Interview Schedule-Revised and Mental Health Inventory-5 were used for screening depressive
symptoms at ages 45 and 50 years, respectively. General and central obesity were defined using measurements of
body mass index (BMI) and waist circumference (WC) at 45 years, respectively.
Results: There was a cross-sectional association between depressive symptoms and obesity: participants with ≥2
depressive symptoms had 31% (95%CI 11% to 55%) higher odds of general and 26% higher odds of central obesity
(95%CI 8% to 47%). In prospective analyses, both general and central obesity were associated with higher odds of
depressive symptoms five years later among women but not in men (Pinteraction < 0.01). After adjustment for depressive
symptoms at baseline, sociodemographic and lifestyle factors, women with general obesity had 38% (95% CI 7% to
77%) and women with central obesity 34% (95%CI 9% to 65%) higher odds of depression compared to others.
Conclusions: Depressive symptoms are associated with concurrent obesity and related lifestyle factors among women
and men in mid-life. Our study suggests that obesity in turn affects long-term risk of depressive symptoms in women
but not in men, independently of concurrent associations, providing an important target group for the implementation
of preventative strategies.
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Background
Obesity and depression are both highly prevalent public
health disorders that affect many age groups and com-
munities [1, 2]. Globally, more than 600 million people
are living with obesity while depression affects over 350
million people [1, 3]. Obesity and depression are interre-
lated; both are known risk factors for cardiovascular dis-
orders and diabetes [4–6], and relate to negative health
and lifestyles factors such as disturbed sleep patterns,
sedentary behaviours and dysregulation in appetite and
food intake [7]. These interrelations are clearly complex
as use of antidepressant medication often leads to weight
gain, as suggested from a review of ten clinical studies
that explored the effect of antidepressants on body
weight [8]. Furthermore, as evidenced by clinical trials
conducted on women [9], dietary restriction targeting
weight reduction in obesity may in turn exacerbate
depression.
Previous observational studies on the association be-
tween obesity and depressive symptoms have provided
mixed findings [10–17], with some suggesting a positive
association [10], while others have reported an inverse
association (obesity associated with lower risk of depres-
sion) [12], no association [13], or a u-shaped association
(higher risk of depressive symptoms among underweight
and obese individuals) [14]. These inconsistencies can
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arise from differences in population characteristics (for
example, ethnicity and age) [12, 15, 18], residual con-
founding [19, 20], or potentially, differences in measures
used to define obesity [21]. For example, a study of 3666
individuals from different ethnic groups in USA sug-
gested an association among White but not Black or
Mexican Americans [18]. A meta-analysis of 13 cross-
sectional obesity-depression association studies (median
n = 1215), indicated differences in point estimates and
statistical precision based on the number of confounders
included in the adjustment [20]. Furthermore, most pre-
vious studies consider “general” obesity, as measured by
body mass index (BMI) [22, 23], while notably less atten-
tion has been paid to potential differences in risk based
on body fat distribution. While BMI is widely used, it
has well-known limitations and may reflect differences
in muscle rather than adipose tissue [21]. Some studies
have associated central obesity, as measured by waist cir-
cumference (WC) or waist-hip ratio (WHR), with de-
pression risk [24]. Adipose tissue is an active endocrine
organ associated with increased inflammatory response
which relates to depression [25]. White adipose tissue
which accumulates typically around the waist is a source
of a range of inflammatory markers, which can pass the
brain-blood barrier and thereby affect depression risk
[26]. Another possibility is that dysregulation of the
hypothalamus-pituitary-adrenal (HPA) axis could in-
crease the accumulation of fat around the abdomen as
well as leading to alterations in mood [27], possibly indi-
cating a greater importance of central rather than gen-
eral obesity with respect to depression risk.
This study used data from a large-scale population-
based cohort to establish whether depressive symptoms
in mid-adulthood are associated with concurrent general
or central obesity and related lifestyle factors, and fur-
ther, whether obesity in turn predicts the longer term
risk of depressive symptoms after accounting for poten-
tial sociodemographic and lifestyle confounders and the
presence of depressive symptoms at baseline.
Methods
Study population
This study used data from 1958 British birth cohort,
which included all born in one week of 1958 in Eng-
land, Scotland and Wales (N = 17,638) with immi-
grants born the same week included up to age
16 years (N = 920) [28]. The cohort has been followed
up until adulthood, and this study primarily used data
from the biomedical survey conducted at age 45 years
(target sample 11,971, data collected for 9377) and
from the 50 year follow-up [29].
Participants with complete information on depressive
symptoms, general and central obesity at age 45 years
were included for cross-sectional analysis (N = 9217).
Individuals from the cross-sectional analysis who also
had information on depressive symptoms at 50 years (N
= 7340) were included in the prospective analysis. The
flow diagram for the selection of participants is shown
in Fig. 1.
Depressive symptoms
Depressive symptoms at 45 years were assessed using
the Clinical Interview Schedule-Revised (CIS-R) [28].
CIS-R was developed for use by lay interviewers as a
screening instrument for 14 common mental disorders
including depression [30]. CIS-R has been reported to
have an acceptable agreement with the Schedule for
Clinical Assessment in Neuropsychiatry (SCAN), a clin-
ical diagnostic tool for depression [31]. In the 1958 co-
hort, the CIS-R was administered by trained nurses;
depressive symptoms were assessed using four questions
that reflect symptom occurrence over the past week.
These include “In the past week have you been able to
enjoy or take an interest in things as much as usual?”,
“In the past week on how many days have you felt sad,
miserable or depressed/unable to enjoy or taken an
interest in things?”, “Did you feel depressed for more
than three hours in any day of the week?”, and “In the
Fig. 1 Flow diagram of the 1958 British Birth cohort for cross-sectional
and prospective study
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last week during depressive periods, did you feel happier
when nice things happened or when you spent time with
your friends?”. Participants presenting with two or more
depressive symptoms were considered as case in our
analyses [32, 33].
Mental Health Inventory − 5 (MHI-5), a short version
of MHI-38, was used to assess depressive symptoms as
part of the postal survey conducted at age 50 years [29]
MHI-5 shows an acceptable validity in screening for de-
pression compared to clinical depression diagnostic tools
and has an equivalent level of performance in screening
depression compared to other screening tools [34, 35].
MHI-5 has five self-administered questions which assess
the amount of time in the past four weeks when the par-
ticipants felt 1) happy, 2) calm and cheerful 3) nervous, 4)
felt down and low or 5) felt like nothing could cheer
them up. Each question was rated using six Likert scale
options (ranging from none to all of the time) to give a
total score range of 5 to 30 [35]. Where needed, scores
were converted to have lower values indicating a greater
prevalence of symptoms and then scaled to 100. Scores
≤52 were used to indicate clinically significant depressive
symptoms [34].
Anthropometric measures
At age 45 years, height, weight and waist circumference
were measured by trained nurses [36]. Weight (in light
clothing) was measured with Tanita solar scales, and
height (without shoes) with a stadiometer. Using a body
tension tape, waist circumference was measured (over
light clothing) between the lower ribs and iliac crest in
the mid-axillary line [36]. BMI was calculated as weight
(kg) over height squared (m2). According to WHO clas-
sification, BMI was categorized into four groups and
coded as underweight (< 18.5), normal (≥18.5 and < 25),
overweight (≥25 and < 30) and obesity (≥30) [37]. Cen-
tral obesity was defined as waist WC ≥102 cm for males
and ≥ 88 cm for females [38].
Covariates
Sociodemographic and lifestyle factors were taken from
age 45 years or from the nearest possible age sweep
where the information was provided. Region of residence
at age 45 years was coded as South, Middle and North-
ern England, London and Scotland; highest educational
level attained by 33 years was grouped as <O level (less
than Secondary education), O level, A level or higher
(further education) [39]; socioeconomic position at birth
(based on father’s occupation, or if missing, from age
7 years) and in adulthood (42 years) was categorised
using the Registrar General Classification, and coded as
I and II (professional/managerial), IIINM (skilled non-
manual), IIIM (skilled manual) and IV and V (partially
skilled and unskilled) [40, 41]. Information on smoking
(currently non-smoker, ex-smoker or smoker), and phys-
ical activity (4–7 times/week, 2–3 times/week, 1 time/
week and < 2–3 times/month), fruit consumption (< 1,
1–2, and ≥ 3 days/week) were collected at 42 years. Alco-
hol consumption (non-drinker; light drinker, < 7 units/
week; moderate drinker, 7–14 units/weeks; heavy
drinker, > 14 units/week), and sedentary behaviour based
on time spent viewing a TV or PC (≥ 3 h and < 3 h/day)
were from the 45 year survey.
Statistical analysis
Logistic regression was used to evaluate both the cross-
sectional and prospective associations. Cross-sectional
analyses of depressive symptoms and obesity (general and
central) included adjustments for sex, region, and social
class at birth and in adulthood. Prospective analyses of
obesity at 45 years and depressive symptoms at 50 years,
included adjustments for sex and baseline depressive
symptoms (model 1), with further adjustment for sociode-
mographic factors (region, social class at birth and in
adulthood; model 2), and for both sociodemographic, and
lifestyle factors (full model, further including alcohol,
smoking, sedentary behaviour, physical activity, and fruit
consumption; model 3). Models 1 to 3 were repeated for
BMI and WC as continuous variables, using linear regres-
sion, to provide trend estimates and to test for curvature
(using a quadratic term) of relationships with depression.
BMI and WC were analysed separately and also mutually
adjusted, to assess their independent effects. Interaction
by sex was tested in cross-sectional and prospective ana-
lyses, and where found, results are presented separately
for men and women.
Information on one or more social or lifestyle covari-
ates was missing for 7% of cohort members. We used
multiple imputation with chained equations (ice com-
mand in Stata) and present results from pooled analyses
of 15 imputed datasets. There were no notable differ-
ences in the effect sizes obtained by analyses using mul-
tiple imputation compared to complete case analyses,
although associations from models with multiple imput-
ation were typically slightly more precise. All analyses
were performed using Stata/ SE 14 software.
Results
At age 45 years, around a quarter of participants were
classified as having general obesity and 35% with central
obesity. The prevalence of depressive symptoms was
8.4% at 45 years and 12.4% at 50 years. Sociodemo-
graphic and lifestyle factors associated with greater
prevalence of general and central obesity were mostly
also associated with higher prevalence of depressive
symptoms (Table 1).
Table 2 shows the cross-sectional associations of de-
pressive symptoms with obesity and lifestyle factors at
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45 years. The odds of obesity were higher for those
reporting ≥2 symptoms compared to individuals with no
depressive symptoms (OR 1.31, 95%CI 1.11 to 1.55 and
OR 1.26, 95%CI 1.08 to 1.47, for general and central
obesity, respectively). The cross-sectional associations
between depressive symptoms and general or central
obesity did not vary by sex (P sex-interaction > 0.33). Num-
ber of depressive symptoms was also related to sedentary
behaviour, smoking and low fruit consumption (P <
0.001 for all comparisons after adjustment for sex, re-
gion, social class at birth and in adulthood). The associ-
ation of depressive symptoms with cigarette smoking
and fruit consumption varied by sex (Psex-interaction < 0.02
for both comparisons), and both associations were ob-
served in women but not men. Compared to women
without symptoms, those with symptoms at baseline had
an OR 1.82 (95% CI 1.38 to 2.19; men OR 1.05, 95% CI
0.78 to 1.40) for smoking and OR 0.51 (95% CI 0.40 to
0.67; men OR 0.76, 95% CI 0.57 to 1.00) for fruit
consumption.
Both general and central obesity at 45 years were asso-
ciated with higher odds of depressive symptoms at age
50 years in women but not in men (Table 3, Psex-interac-
tion < 0.01 for all comparisons). In women, the observed
associations between BMI and WC with depressive
symptoms were somewhat attenuated by adjustment for
sociodemographic and lifestyle factors, but for both
obesity indicators the associations remained even after
accounting for baseline symptoms, sociodemographic
and lifestyle factors (BMI: OR per 10 kg/m2 1.36, 95%CI
1.15 to 1.62; WC: OR per 5 cm 1.07, 95%CI 1.03 to
1.11). In men the fully adjusted OR for BMI was 0.83
(95%CI 0.64 to 1.10, Ptrend = 0.20) and for WC 0.99
(95%CI 0.94 to 1.04, Ptrend = 0.67). In a model including
all covariates and mutually adjusted for BMI and WC,
the association in women for BMI was abolished (OR
0.96, 95%CI 0.77 to 1.18) while the estimate for WC
remained significant (OR 1.08, 95%CI 1.02 to 1.15).
Again, the corresponding mutually adjusted model
among men did not suggest an association either for
WC or BMI (P > 0.16 for all comparisons).
To further understand the association between obesity
and depressive symptoms, we explored the prospective
associations between lifestyle factors and depressive
symptoms. Alcohol consumption, smoking, sedentary
behaviour and fruit consumption were all associated
with depressive symptoms at 50 years after adjustment
for depressive symptoms at 45 years, sex, sociodemo-
graphic and other lifestyle factors (Table 4). The pres-
ence of depressive symptoms at age 45 years was
associated with an over four-fold greater odds of depres-
sive symptoms at 50 years, attenuating only slightly after
adjustment for obesity and lifestyle factors (OR reduced
from 4.43 (95%CI 3.61 to 5.43) to 4.11 (95%CI 3.34 to
5.06)), suggesting further unmeasured influences on the
tracking of depressive symptoms.
Discussion
Tackling the current obesity epidemic both in terms of
addressing its causes and consequences remains a key
public health priority. Mental wellbeing has broad influ-
ences on health and as shown in our large-scale study,
the presence of depressive symptoms is strongly associ-
ated both with obesity and a broad range of related life-
style factors. However, as shown in our analyses, even
after controlling for these concurrent associations, obes-
ity several years earlier appears to affect subsequent
odds of depressive symptoms among women but not in
men, providing an important target group for implemen-
tation of preventative strategies. Furthermore, this study
provided some support for the hypothesis that central
rather than general adiposity may have a key role in con-
tributing to the association between obesity and the risk
of developing depressive symptoms, highlighting the
need of further studies to establish related mechanisms
and pathways.
Our work builds on an earlier analysis in the 1958 co-
hort, which suggested that when looking at categories of
BMI from childhood to adulthood (age 7 onwards) obes-
ity was associated with the subsequent odds of depres-
sive symptoms in women but not in men [15]. Inclusion
here of central obesity is important because BMI has
known weaknesses, especially for men, due to the strong
correlation with muscle mass [21]. The result from our
previous work [15] is consistent with the current study,
and both the analysis using BMI (or general obesity) and
WC (or central obesity) suggest that obesity is affecting
the likelihood of developing depressive symptoms in
women only.
Our findings for higher odds of depressive symptoms
by general and central obesity are consistent with several
other previous studies [20, 22]. For example, a meta-
analysis including eight cross-sectional studies reported
the odds of depression to be 35% higher in people with
obesity compared to normal weight individuals [42]. A
meta-analysis reporting prospective associations also in-
cluded eight studies, six of them assessed to be of poor
quality by the authors, suggesting an overall 55% higher
odds of depression for those with obesity compared to
normal weight, with no evidence for sub-group differ-
ences by sex [22]. Another meta-analysis including 15
studies showed 38% higher odds of depression in indi-
viduals with central obesity compared to those without,
with higher estimates among women than men [20]. Im-
portantly, unlike these previous studies [20, 22], our
study included an adjustment for depressive symptoms
at baseline. Furthermore, the weaker effect estimate in
our study compared to previous meta-analyses may be
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Table 1 Characteristics and distributions of adult obesity and depressive symptoms by sociodemographic and lifestyle factors






Depressionb age 45y N (%) Depressionc age 50y N (%)d
All 9217 27.4 (5.0) 2251 (24.4) 3208 (34.8) 776 (8.4) 911 (12.4)
Gender
Male 4591 (49.8) 27.8 (4.3) 1162 (25.3) 1503 (32.7) 322 (7.0) 369 (10.5)
Female 4626 (50.2) 26.9 (5.6) 1089 (23.5) 1705 (36.9) 454 (9.8) 542 (14.2)
P < 0.001 0.05 < 0.001 < 0.001 < 0.001
Social class age 42
I & II 3715 (40.3) 27.2 (4.7) 813 (21.9) 1188 (32.0) 231 (6.2) 287 (9.4)
IIINM 1916 (20.8) 26.9 (5.0) 419 (21.9) 663 (34.6) 172 (9.0) 222 (14.0)
IIIM 1711 (18.6) 28.1 (4.9) 493 (28.8) 598 (35.0) 127 (7.4) 150 (11.6)
IV & V 1469 (15.9) 27.8 (5.5) 423 (28.8) 593 (40.4) 167 (11.4) 183 (16.3)
Others 406 (4.4) 27.7 (5.6) 103 (25.4) 166 (40.9) 79 (19.5) 69 (25.8)
Pa < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Alcohol (units/week)
Non-drinker 623 (6.8) 28.2 (6.3) 193 (31.0) 253 (40.6) 108 (17.3) 114 (24.8)
Light < 7 4476 (48.6) 27.6 (5.3) 1196 (26.9) 1, 642 (36.7) 367 (8.2) 428 (11.9)
Moderate 7–14 2226 (24.2) 26.8 (4.3) 431 (19.4) 679 (30.5) 137 (6.1) 185 (10.2)
Heavy > 14 1854(20.0) 27.3 (4.6) 214 (21.0) 616 (33.2) 160 (8.6) 182 (12.6)
Missing 38 (0.4) 27.3 (4.6) 10 (26.3) 18 (47.4) 4 (10.5) 2 (11.1)
Pa < 0.001 < 0.001 < 0.001 0.002 0.008
Smoking
Never 4256 (46.1) 27.4 (5.0) 1024 (24.1) 1440 (33.8) 307 (7.2) 386 (10.9)
Ex- smoker 2497 (27.1) 27.8 (5.0) 645 (25.8) 914 (36.6) 185 (7.4) 217 (8.7)
Current smoker 2161 (23.5) 27.0 (5.1) 520 (24.1) 752 (34.8) 249 (11.5) 282 (13.1)
Missing 303 (3.3) 27.0 (4.7) 62 (20.5) 102 (33.7) 35 (11.6) 26 (14.1)
Pa 0.49 0.31 0.05 < 0.001 < 0.001
Physical activity
< 2–3 times/monthe 3026 (32.8) 28.0 (5.5) 878 (29.0) 1229 (40.6) 317 (10.5) 352 (14.9)
1 time/week 1670 (18.1) 27.4 (4.8) 415 (24.9) 565 (33.8) 104 (6.2) 144 (10.4)
2–3 times/week 1932 (21.0) 27.1 (4.5) 413 (21.4) 612 (31.7) 138 (7.1) 161 (10.3)
4–7 times/week 2295 (24.9) 26.9 (4.9) 484 (21.1) 703 (30.6) 181 (7.9) 227 (12.2)
Missing 294 (3.2) 26.9 (4.3) 61 (20.8) 99 (33.7) 36 (12.2) 27 (15.3)
Pa < 0.001 < 0.001 < 0.001 < 0.001 0.003
Sedentary behaviour
< 3 h/day 5806 (63.0) 26.9 (4.7) 1195 (20.6) 1751 (30.2) 429 (7.4) 517 (11.0)
≥ 3 h/day 2995 (32.5) 28.4 (5.4) 945 (31.6) 1296 (43.3) 293 (9.8) 348 (14.9)
Missing 416 (4.5) 27.7 (5.4) 111 (26.7) 161 (38.7) 54 (13.0) 46 (16.7)
Pa < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Fruit consumption
< 1 day/week 1676 (18.2) 27.5 (5.0) 433 (25.8) 618 (36.9) 195 (11.6) 220 (17.5)
1–2 days/week 1367 (14.8) 27.5 (5.1) 349 (25.5) 506 (37.0) 113 (8.3) 161 (15.1)
≥ 3 days/week 5879 (63.8) 27.4 (5.0) 1407 (23.9) 1984 (33.8) 432 (7.4) 503 (10.4)
Missing 295 (3.2) 27.0 (4.3) 62 (21.0) 100 (33.9) 36 (12.2) 27 (15.3)
Pa 0.74 0.13 0.001 < 0.001 < 0.001
aP-value from logistic regression adjusted for sex
bDepressive symptoms measured using CIS-R
cDepressive symptoms measured using MHI-5. d Cohort members who had missing data on depressive symptoms at age 50 (n = 1, 877) have been
excluded. e include individuals who responded no for “Do you do any regular exercise?”
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due to better control for sociodemographic or other
confounding factors as most previous studies included
in the two meta-analyses [20, 22, 42] were either un-
adjusted or adjusted for limited set of confounders.
We observed a dose-dependent increase in the odds of
depressive symptoms by categories of BMI, which is
consistent with most previous studies [10, 13, 43]. How-
ever, in some studies, the association between general
obesity and depressive symptoms has favoured the “Fat
and Jolly” hypothesis, suggesting that obesity may pro-
tect against depression [44] while others show a higher
odds both for the very thin and obese individuals com-
pared to those with normal weight [14, 16, 45]. It is pos-
sible that an increased odds of depression for those who
are thin or underweight, can reflect sub-optimal health
status [46]. These inconsistencies among studies could
be further explained by contextual, and psychosocial
influences contributing to the obesity – depression rela-
tionship. Individuals who experience stigma and discrim-
ination due to their weight may have low self-esteem
and high degree body image dissatisfaction that further
aggravate psychological stress and lead to depressive
Table 2 Cross-sectional association of depressive symptoms with obesity and lifestyle factors at age 45 years
Obesity, OR (95% CI)a Lifestyle factorsb, OR (95% CI)a
Nc (%) General obesity Central obesity Sedentary behaviour High alcohol consumption Current smoking Fruit consumption
Depressive symptoms
None 7683 (83.4) Reference Reference Reference Reference Reference Reference
1 758 (8.2) 1.07 (0.90, 1.27) 1.02 (0.87, 1.19) 1.36 (1.16, 1.59) 1.15 (0.95, 1.40) 1.47 (1.23, 1.74) 0.82 (0.68, 1.00)
≥ 2 776 (8.4) 1.31 (1.11, 1.55) 1.26 (1.08, 1.47) 1.30 (1.10, 1.53) 1.19 (0.99, 1.44) 1.53 (1.30, 1.82) 0.52 (0.53, 0.76)
Punadjusted 0.001 < 0.001 < 0.001 0.89 < 0.001 < 0.001
Padjusted
a 0.005 0.01 < 0.001 0.08 < 0.001 < 0.001
Psex-interaction
d 0.33 0.58 0.52 0.11 < 0.001 0.02
aP-value adjusted and OR (95% CI): adjustment made for sex, region, social class at birth and social class at age 42 years
bSedentary behaviour, spent 3 or more hrs/day viewing a TV or PC; high alcohol consumption, > 15 units/week alcohol consumption; current smoking, smoking
during age 42 sweep; fruit consumption, < 1 day/week fruit consumption vs > 1 day/week fruit consumption
cAll the analysis done in 9217 sample population of the age 45
dInteraction between sex and depressive symptoms on obesity and on lifestyle factors after adjustment for sex, region, social class at birth and social class at
age 42 years
Table 3 Prospective association between general and central obesity at age 45 years and depressive symptoms at age















Underweight 0.72 (0.21, 2.49) 0.72 (0.20, 2.50) 0.54 (0.15, 1.99) 2.47 (0.45, 13.05) 2.30 (0.41, 12.80) 1.91 (0.33, 11.21)
Normal Reference Reference Reference Reference Reference Reference
Overweight 1.11 (0.87, 1.40) 1.08 (0.85, 1.38) 1.10 (0.86, 1.40) 0.87 (0.64, 1.13) 0.87 (0.65, 1.15) 0.86 (0.65, 1.15)
Obesitya 1.56 (1.22, 1.98) 1.46 (1.14, 1.86) 1.38 (1.07, 1.77) 0.87 (0.63, 1.21) 0.87 (0.63, 1.21) 0.85 (0.61, 1.18)
Per 10 kg/m2 1.48 (1.26, 1.74) 1.41 (1.20, 1.67) 1.36 (1.15, 1.62) 0.87 (0.66,1.14) 0.86 (0.65,1.12) 0.83 (0.64,1.10)
Ptrend < 0.001 < 0.001 < 0.001 0.31 0.26 0.20
Pcurvature 0.25 0.19 0.32 0.05 0.11 0.14
Waist circumference
Normal Reference Reference Reference Reference Reference Reference
Central obesityb 1.48 (1.21, 1.81) 1.41 (1.15, 1.73) 1.34 (1.09, 1.65) 0.97 (0.75, 1.23) 0.94 (0.73, 1.21) 0.90 (0.70, 1.17)
Per 5 cm 1.10 (1.06, 1.14) 1.09 (1.05, 1.13) 1.07 (1.03, 1.11) 1.00 (0.95, 1.05) 1.00 (0.95, 1.05) 0.99 (0.94, 1.04)
Ptrend < 0.001 < 0.001 < 0.001 0.99 0.88 0.67
Psex-interaction is the interaction between sex and obesity variables at age 45 years on depression at age 50 years (For all obesity variables, Psex-interaction < 0.01)
Model-1, adjusted for depressive symptoms at age 45 years; Model-2, adjusted for depressive symptoms at age 45 years, and region, social class at birth and
social class at adulthood; Model-3, adjusted for depressive symptoms at age 45 years, region, social class at birth, social class at adulthood, fruit consumption,
physical activity, sedentary behaviour, smoking, alcohol)
aBMI ≥ 30 kg/m2
bWC ≥ 102 cm for men and WC ≥ 88 cm for women
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symptoms [47]. Indeed, the possible stigma and discrim-
ination due to excessive body weight is likely to have a
greater impact on women than men which may explain
the observed gender difference [47].
Mechanisms underlying the association between
obesity and depression remains unclear, however, mo-
lecular and clinical studies have provided some evi-
dence for the involvement of HPA axis, inflammatory
pathways and insulin sensitivity [48], with dysregulation
of HPA axis, elevation of certain inflammatory markers
and insulin resistance being observed in both individ-
uals with obesity and in individuals with depression
[49–51]. Disturbance in any of these systems may affect
the secretion or metabolism of neurotransmitters, such
as serotonin, norepinephrine and dopamine, in the
brain and consequently influence mood [48, 52]. Findings
regarding inflammatory pathways and insulin sensitivity
are particularly interesting: the observed elevated inflam-
matory markers, including leptin, adiponectin and IL-6
and TNF-α are mainly secreted from white adipose tissue
found on the abdomen [26]; abdominal obesity, in particu-
lar, places people at higher risk for developing insulin re-
sistance [53]. All these observations resonate with our
findings of an independent association for WC and
Table 4 Lifestyle factors and the risk of depressive symptoms at age 50 years
Adjusted for sex, depressive symptoms at 45y, & other factorsa Full adjustmentb
OR(95%CI) OR(95%CI) Psex-interaction
Alcohol 0.40
Non-drinker 1.98 (1.52, 2.58) 1.88 (1.44, 2.46)
Light < 7 units/week Reference Reference
Moderate 7–14 units/week 0.98 (0.80, 1.19) 1.00 (0.82, 1.22)
Heavy > 14 units/week 1.23 (1.00, 1.51) 1.17 (0.95, 1.45)
P < 0.001 < 0.001
Smoking 0.05
Never Reference Reference
Ex-Smoker 0.96 (0.80, 1.16) 0.93 (0.77, 1.13)
Current smoker 1.51 (1.25, 1.81) 1.33 (1.09, 1.61)
P < 0.001 0.003
Physical activity 0.51
2–3 times/month Reference Reference
1 time/week 0.79 (0.63, 0.98) 0.88 (0.71, 1.10)
2–3 times/week 0.76 (0.61, 0.94) 0.88 (0.70, 1.09)
4–7 times/week 0.86 (0.71, 1.05) 0.98 (0.81, 1.20)
P 0.04 0.52
Sedentary behaviour 0.09
< 3 h/day Reference Reference
≥ 3 h/day 1.36 (1.16, 1.59) 1.20 (1.02, 1.41)
P < 0.001 0.05
Fruit consumption 0.02
< 1 day/week Reference Reference
1–2 days/week 0.93 (0.73, 1.18) 0.98 (0.76, 1.25)
≥ 3 days/week 0.60 (0.49, 0.73) 0.67 (0.55, 0.82)
P < 0.001 < 0.001
Depressive symptoms at age 45y 0.36
No Reference Reference
Yes 4.43 (3.61, 5.43) 4.11 (3.34, 5.0)
P < 0.001 < 0.001
P-value based on Likelihood ratio test
aSociodemographic factors included region, social class at birth and social class at age 42 years
bFull adjustment involved sex, depressive symptoms at age 45 years, sociodemographic factors, general and central obesity, alcohol, smoking, physical activity,
sedentary behaviour, and fruit consumptions
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highlight the particular importance of central obesity on
the risk of developing depressive symptoms.
Our study also suggests that the association between
obesity and depressive symptoms is in part related to so-
cioeconomic and lifestyle factors, with obesity associa-
tions attenuating by about 30% after allowing for such
factors. This attenuation was expected considering that
most studies show lower socioeconomic status and un-
healthy lifestyle factors to be associated with obesity and
depression [54, 55] although some factors may be on the
causal pathway from obesity to depressive symptoms.
For example, obesity may lead to less active lifestyles as
well as inactivity increasing the risk of obesity [56]. Even
so, given the links shown here between lifestyle factors
and depressive symptoms, our study suggests that these
behaviours may be additional targets for interventions to
reduce obesity and depression.
Limitations
It is important to emphasise the following limitations of
this study. Firstly, our study used the presence of depres-
sive symptoms as the outcome rather than defining it
based on the diagnosis of depressive disorder. In an earl-
ier meta-analysis, the association between obesity and
depression was found to be stronger for depressive dis-
order than for depressive symptoms [22]. This may ex-
plain why the associations found here are weaker than
other reported estimates. Different instruments were
used to assess depressive symptoms at ages 45 and
50 years, although both have been shown to be valid,
with similar performance compared to standard diagnos-
tic tools and both have been used in community-based
epidemiological studies for screening of depressive
symptoms [57, 58]. Another limitation relates to repre-
sentativeness, as the ethnic composition of the current
UK population is notably more diverse compared to the
participants included here, 98% of whom were European
origin [28]. Hence, the results may not be generalisable
to today’s more ethnically diverse population in the UK.
A further limitation relates to inadequately measured or
unmeasured confounding: although a broad range of
lifestyle and sociodemographic factors were included,
some measures (e.g. sedentary behaviour, physical activ-
ity) may have limitations, whilst in total the measures
may not have captured all variation influencing the asso-
ciation between obesity and depressive symptoms. Fi-
nally, our study is limited in its ability to fully dissect
independent effects of general and central adiposity.
BMI and WC are highly correlated, and while our ana-
lyses suggest that WC may be the major influence, fur-
ther studies avoiding problems with collinearity are
needed to confirm this interpretation. Alternative ap-
proaches such as Mendelian randomisation may provide
further insights into the independent causal roles of cen-
tral and general obesity on depression risk.
Conclusion
Depressive symptoms are associated with obesity and re-
lated lifestyle factors in mid-life. Our study suggests that
obesity affects subsequent risk of developing depressive
symptoms among women independently of these concur-
rent associations, providing an important target group for
implementation of preventative strategies. In the manage-
ment of depressive symptoms, one of the alternative ap-
proaches could be targeting and managing obesity and
unfavourable lifestyle factors.
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